4//SEC Filing
Pinto Alexis 4
Accession 0001725160-20-000020
CIK 0001725160other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 9:16 PM ET
Size
5.6 KB
Accession
0001725160-20-000020
Insider Transaction Report
Form 4
Pinto Alexis
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-08-31+275,000→ 275,000 totalExercise: $34.40Exp: 2030-08-30→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable as to 25% of the total number of shares underlying the option on August 31, 2021 and as to the remaining 75% in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001819302
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 9:16 PM ET
- Size
- 5.6 KB